Brian Stephenson, Ph.D. will depart from the Company for personal reasons. Dr. Stephenson's departure was not the result of a disagreement with the Company on any matters relating to the Company’s ...
29m
Announced positive preliminary 12-week clinical results, building on already released 4-week results, of ongoing type 1 diabetes study showing ...
US-listed floating regasification specialist Excelerate Energy has signed an initial deal with Vietnam’s state energy company ...
(Reuters) -Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback